Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1993Journal of Clinical MicrobiologyOpen Access

Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAlison ThomasQueen Mary University of LondonHSHenry R. SmithGriffith UniversityBRB. RoweStatens Serum Institut

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thomas et al. (1993) studied this question.

synapsesocial.com/papers/6a8419b2002ab1506fb29892https://doi.org/10.1128/jcm.31.7.1700-1703.1993
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis1991 · 164 citations
  2. 2Development of verotoxin 2- and verotoxin 2 variant (VT2v)-specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F11991 · 50 citations
  3. 3Chromosomal genotypes (evolutionary lines) ofSalmonella berta1992 · 18 citations
  4. 4Vero cytotoxin-producing strains of Escherichia coli1988 · 88 citations